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Lance and Taub (1) showed that when radioactively  labeled lymphocytes were 
injected  into  a  syngeneic  mouse  and  the  lymph  node  cells  of  this  animal 
transferred to a second syngeneic recipient, the proportion of radioactivity  found 
in the lymph node relative to the amount present in the spleen of the secondary 
recipient had  increased markedly.  The  interpretation of this result was that 
some lymphocytes have the capacity to "home" to their organ of origin. 
The  purpose  of the  experiments described here  was  to  test  the  "homing" 
capacity of T  cells by a  method that did not involve radioactive labeling. It has 
been shown elsewhere that some or all mouse T cells are stimulated to divide in 
culture by the mitogens phytohemagglutinin (PHA) and concanavalin A (Con A) 
(2).  We  therefore  elected  to  inject  karyotypically distinct  lymphocytes  into 
syngeneic recipients and to follow their subsequent distribution by culture of 
lymph node and spleen cells of the recipient with PHA or Con A. In this manner 
the homing capacities of spleen and lymph node T cells could be determined, and 
furthermore,  the  effects of labeling with chromium-51 ('~lCr)  could be  assayed 
with respect to the persistence of mitogen responsiveness in the injected cells. 
Materials  and  Methods 
Three  syngeneic  strains of mice were  used,  CBA/Lac (Lac), CBA/H-T6T6 (T6T6), and the 
progeny of hybridization of these two strains (LT6F). 
Adult thymectomy,  irradiation, and reconstitution with syngeneic  bone marrow  cells  were 
performed  in the manner described previously (3). The methods for preparation of spleen  and 
mesenteric lymph node cell suspensions, both for injection and for culture in vitro are described in 
Doenhoff et  al.  (2), and  those  for the  isolation of blood cells  for  culture are  to  be found  in 
Festenstein (4). Mouse lymphocytes were cultured with PHA and Con A, and cells were arrested in 
metaphase with Colcemid (Ciba, Horsham,  England) as described by Doenhoff et al. (2), meta- 
phase preparations being made according to the method of Ford (5). 
Spleen cell suspensions  to be labeled with ~lCr were prepared from T6T6 and LT6F mice and 
pretreated with Tris-buffered  ammonium  chloride solution to remove red cell elements (6). The 
suspension was washed twice in TC 199 medium with 10% fetal bovine serum, and a final vol of 2 
ml containing l0  s nucleated cells/ml was prepared. To this 2-ml vol were added 50 p.1 of radioactive 
sodium chromate solution (approximately 200 mCi/mg Cr, 1 mCi/ml; The Radiochemical Centre, 
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Amersham, England). The cells were incubated for 40 rain at 37°C before being washed three times 
in fresh TC 199. After the third centrifugation, the cells were resuspended and recounted before 
being mixed  with an  equal  number of karyotypically distinct spleen cells that had also  been 
labeled  with  51Cr  or  had  been  treated  in  exactly  the  same manner except  for  addition  of  radioactive 
chromium. 
The T6T6 and LT6F cells  were found to have incorporated radioactive chromate ions  to 
approximately the same extent (4,428  and 4,848  dpm/10  ~  nucleated cells/0.1  ml, respectively,  as 
measured in a Wallac Gecem GTL gamma counter [Wallac Instruments, Turku, Finland]).  Cell 
viability  immediately  after  treatment (as  adjudged  by trypan  blue dye  exclusion)  was  between 80 
and 88%, with no consistent  difference  between radioactively  labeled  and unlabeled cells. 
Results 
In the first  experiment, spleen  and mesenteric lymph node cells  suspensions 
were prepared from LT6F and T6T6 mice,  respectively.  These two cell  types 
were mixed together  to give  a suspension which contained 120 × 108  nucleated 
cells/ml,  half  the cells  being derived from spleen  and half  from lymph node.  A 
vol of 0.5 ml (30  x  10  e cells of each type) was injected intravenously into five 
adult thymectomized Lac mice that had received a sublethal dose of 350 R total 
body irradiation  30 days previously. 20 h  after the injection the blood, spleen, 
and  mesenteric  lymph  node cells  of the  recipient  animals  were prepared  for 
culture with  Con A  and  PHA,  and the  cultures  were subjected to cytological 
analysis of the dividing cells after harvesting 3 days later. 
With both T-cell mitogens, the mean ratio of donor spleen: donor lymph node 
derived cells found  in  division  was  approximately  4:6  in  both the  recipients' 
lymph node and spleen cultures,  and marginally higher than this in the blood 
cultures (Fig.  I a). This ratio correlates reasonably with results for the relative 
number of 0-positive (7) and T-cell mitogen-responsive cells (8) present in spleen 
and lymph node. However, a greater proportion of donor cells of both types was 
found in the spleen cultures of the partially  irradiated  recipients than  in the 
blood or lymph node cultures (Fig.1 b). 
The second experiment was designed to investigate whether the procedure of 
labeling lymphocytes with 5~Cr had an effect on the fate of these cells when they 
were subsequently  injected  into syngeneic  recipients.  In  this  experiment  the 
cells  were  in  effect doubly  labeled,  firstly  as  a  result  of bearing  distinctive 
chromosome  markers,  and  secondly with  51Cr. However,  the  cells  would  be 
traced by means of the former characteristic only. 
Thus, radioactively labeled and unlabeled karyotypically distinct spleen cells 
were  mixed  with  each  other  in  four  combinations:  (a)  unlabeled  T6T6  plus 
unlabeled  LT6F;  (b) unlabeled T6T6 plus labeled LT6F;  (c) labeled T6T6 plus 
unlabeled LT6F; and (d) both T6T6 and LT6F labeled. Each of the four mixtures 
contained  50  x  10  s  cells  of each  karyotype/ml,  and  a  vol  of 0.5  ml  of each 
suspension was injected into two Lac mice which had been adult thymectomized, 
irradiated with 850 R, and reconstituted with 5  ×  10  e Lac bone marrow cells 30 
days previously. 1 wk later the lymph node, spleen, and blood cells of the eight 
recipient  mice were cultured  with PHA for karyotype analysis of cells stimu- 
lated into metaphase. 
In  cultures  of the  mice  given  nonradioactive  cells,  the  ratio  of dividing 
T6T6:LT6F cells was approximately 1:1 (Fig. 2), which is to be expected because 
the two cell types were present in equal numbers in the injected cell inoculum. 662  DOENHOFF  AND  DAVIES  BRIEF  DEFINITIVE  REPORT 
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Fro.  1.  (a) The proportion of LT6F cells found in metaphase in Con A (C) and PHA (P) 
cultures of spleen, lymph node, and blood cells obtained from adult thymectomized 350 R 
irradiated Lac mice injected 20 h previously with a mixture containing equal numbers of 
LT6F  spleen cells and  T6T6  lymph  node  cells.  The  results  give the  number  of LT6F 
metaphases as a percentage of the total number of cells of donor (LT6F plus T6T6) origin 
scored. Each histogram bar represents the mean value observed in five cultures prepared 
from five mice -+ the standard deviation. (b) The number of donor cells (LT6F spleen plus 
T6T6 lymph node) observed in metaphase in the same cultures as Fig. 1 a, expressed as a 
percentage of all mitosing cells (donor plus Lac host) scored. 
However,  in  mice given a  mixture  of labeled and unlabeled  cells, the ratio of 
responding  cells  of  donor  origin  was  distorted  such  that  a  greater  relative 
number  of PHA-responsive  cells  of the  karyotype  not  labeled  with  5~Cr  was 
found. It would appear that as many as 75% of the cells treated with 5~Cr were no 
longer  in  a  mitogen-responsive  state  within  a  week  of injection,  though  the 
evidence for this is less marked  in the blood cultures than  in either spleen or 
lymph  node  cultures.  In  the  two  mice  which  received  labeled  cells  of both 
karyotypes, the ratio was restored more towards the  1:1 level. 
During cytological analysis of these cultures, a  number  of cells were observed 
to have  abnormal  chromosomes.  These  cells could have  been irradiation-dam- 
aged host cells, but in many  of them  minute  chromosomes similar to the T6T6 
marker  chromosomes could be identified and these metaphases  were only com- 
mon in the mice that  had received cells labeled with 5~Cr. DOENHOFF  AND  DAVIES 
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Fro.  2.  The  proportion  of T6T6  cells  observed  in  metaphase  cultures  of lymph  node, 
spleen, and blood cells taken from adult thymectomized, irradiated, bone marrow-reconsti- 
tuted Lac recipients which had been injected 7 days previously with a  mixture containing 
equal  numbers of T6T6  and  LT6F  spleen  cells.  The  donor  cell  types  which  had  been 
incubated with radioactive sodium chromate before injection are indicated by +. Each point 
is the number of T6T6  cells found dividing as a  percentage of the total  number of donor 
(T6T6 plus LT6F)  cells scored in the cultures,  and represents the  value for one recipient 
animal. 
Discussion and Summary 
If injected, mitogen-responsive T cells were capable of"homing" to the same 
peripheral  lymphoid  organ  in  the  recipient  as  the  donor  organ  they  were 
originally taken from, it would be expected that the ratio of donor lymph node to 
donor spleen PHA- and Con A-responsive cells would be higher in the recipients' 
lymph node and lower in the recipients' spleen. However, the results given in 
Fig.  1 a  imply that the pattern of distribution of injected mitogen-responsive 
cells is independent of the tissue of origin of the injected cells, at least when the 
recipients are assayed 20 h  after injection. 
The results of the second experiment (Fig. 2) suggest that in terms of survival, 
mitogen-responsive T cells which have been labeled with 5'Cr are at a substan- 
tial disadvantage when compared with equivalent unlabeled cells. The labeled 
cells may only have lost their capacity to respond to the mitogen, o~ they could 
have  been removed from the  circulation  of the recipient  animal  because  of 
irreversible physiological damage inflicted by the sodium chromate. Further- 
more it is not known whether the toxicity demonstrated here was induced by the 
chromate ions per se or by 7-irradiation from the mCr, though damage that may 
have  been  elicited  by  the  radioactive  chromium was  noted  in  the  form  of 
chromosome breaks. The recirculatory properties of labeled cells, while, and if, 
they survive, may also be changed as a  result of the labeling procedure, since 664  DOENHOFF  AND  DAVIES  BRIEF  DEFINITIVE  REPORT 
relatively fewer  labeled  cells  were  found responding to  PHA  in  spleen  and 
lymph node cultures of the recipients than in blood cultures (Fig. 2). 
In experiments which have involved the injection of 51Cr_treated cells, the role 
that the recipient animals' phagocytic system plays in determining the distribu- 
tion  of the  radioactivity had  rarely  been  taken  into  account.  Most  of the 
radioactivity which can be recovered after systemic injection of labeled cells is 
found in the recipients' spleen and liver (1), and both of these organs could have 
been responsible for removing many of the 51Cr-labeled  cells which were  no 
longer to be found in a mitogen-responsive state 1 wk after injection (Fig. 2). 
Resolution of the discrepancies concerning the "homing" potential of lympho- 
cytes may eventually depend on determining by autoradiography the distribu- 
tion pattern of injected lymphocytes that have incorporated nontoxic doses of 
tritium-  or  carbon-~4-1abeled  nucleotides,  and comparing it  with the  pattern 
shown by cells that have in addition been labeled with ~Cr. 
In summary, (a) no evidence has been found for the ability of PHA- and Con 
A-responsive lymphocytes to differentially migrate to their peripheral lymphoid 
organ of origin after injection into syngeneic recipients, using mitogen stimula- 
tion in tissue culture and chromosome markers to trace the distribution of the 
injected cells; and (b) one of the methods used previously to obtain this evidence, 
namely, the labeling of lymphocytes with '~lCr, has been shown to impair the 
capacity of such cells to respond to in vitro stimulation with PHA at a later time. 
Our interest in the phenomenon germinated in discussion with Dr P. Hersey. We are indebted to 
Dr P. Frost for advice on the methods of radioactively labeling lymphocytes; to Dr R. Kerbel for 
excellent technical assistance; to Dr J. G. Hall for critically reading the manuscript; and to Miss 
M.  Butt for secretarial help. 
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